Picture of Quantum Genomics SA logo

ALQGC — Quantum Genomics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Quantum genomics receives authorisation to begin Phase IIA multicentric European trial

April 26 (Reuters) - Quantum Genomics SA  ALQGC.PA : 
    * Regulatory authorisations received in France to begin Phase IIA multicentric European 
trial for heart failure 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nACT43924 
Further company coverage:  ALQGC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Quantum Genomics SA

See all news